# Adoptive Transfer of Haploidentical NK Cells and N-803

> **NCT03899480** · PHASE1 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 9 (actual)

## Conditions studied

- Hiv
- HIV Infections
- Immune Deficiency

## Interventions

- **BIOLOGICAL:** Haploidentical Natural Killer (NK) Cells

## Key facts

- **NCT ID:** NCT03899480
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899480, "Adoptive Transfer of Haploidentical NK Cells and N-803". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03899480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*